Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra L Simmons

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Archives of Internal Medicine|June 29, 2005
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Paul K Whelton, Joshua Barzilay, William C Cushman, et al.
American Heart Journal|December 1, 2012
Cardiovascular risk assessment: addition of CKD and race to the Framingham equationPaul E Drawz, Sarah Baraniuk, Barry R Davis, et al.
Circulation. Cardiovascular Quality and Outcomes|March 8, 2012
Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension StudyJoshua I Barzilay, Barry R Davis, Sara L Pressel, et al.
Diabetes Care|June 23, 2012
Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trialAnn V Schwartz, Karen L Margolis, Deborah E Sellmeyer, et al.
BMJ (Clinical Research Ed.)|January 12, 2010
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD studyDenise E Bonds, Michael E Miller, Richard M Bergenstal, et al.
Journal of the American Heart Association|July 17, 2019
Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINTLama Ghazi, Nicholas M Pajewski, Dena E Rifkin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 2015
Effects of TZD Use and Discontinuation on Fracture Rates in ACCORD Bone StudyAnn V Schwartz, Haiying Chen, Walter T Ambrosius, et al.
BMJ Open|February 16, 2023
Couple-based lifestyle intervention to prevent type 2 diabetes: protocol for a randomised pilot trialMadelyn Whitaker, Monique C Aguirre, Manuel Gutierrez Chavez, et al.
The New England Journal of Medicine|August 24, 2017
Effect of Intensive Blood-Pressure Treatment on Patient-Reported OutcomesDan R Berlowitz, Capri G Foy, Lewis E Kazis, et al.
Archives of Internal Medicine|January 30, 2008
Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Jackson T Wright, Sonja Harris-Haywood, Sara Pressel, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Archives of Internal Medicine|June 29, 2005
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Paul K Whelton, Joshua Barzilay, William C Cushman, et al.
American Heart Journal|December 1, 2012
Cardiovascular risk assessment: addition of CKD and race to the Framingham equationPaul E Drawz, Sarah Baraniuk, Barry R Davis, et al.
Circulation. Cardiovascular Quality and Outcomes|March 8, 2012
Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension StudyJoshua I Barzilay, Barry R Davis, Sara L Pressel, et al.
Diabetes Care|June 23, 2012
Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trialAnn V Schwartz, Karen L Margolis, Deborah E Sellmeyer, et al.
BMJ (Clinical Research Ed.)|January 12, 2010
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD studyDenise E Bonds, Michael E Miller, Richard M Bergenstal, et al.
Journal of the American Heart Association|July 17, 2019
Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINTLama Ghazi, Nicholas M Pajewski, Dena E Rifkin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 2015
Effects of TZD Use and Discontinuation on Fracture Rates in ACCORD Bone StudyAnn V Schwartz, Haiying Chen, Walter T Ambrosius, et al.
BMJ Open|February 16, 2023
Couple-based lifestyle intervention to prevent type 2 diabetes: protocol for a randomised pilot trialMadelyn Whitaker, Monique C Aguirre, Manuel Gutierrez Chavez, et al.
The New England Journal of Medicine|August 24, 2017
Effect of Intensive Blood-Pressure Treatment on Patient-Reported OutcomesDan R Berlowitz, Capri G Foy, Lewis E Kazis, et al.
Archives of Internal Medicine|January 30, 2008
Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Jackson T Wright, Sonja Harris-Haywood, Sara Pressel, et al.
Pageof 4